Mitsubishi Research Institute (3636) AI Stock Analysis

• Market Cap: ¥74.49B
• Dividend Yield: 3.4%
• Average Volume (3M): 30.78K
• Price to Earnings (P/E): 20.2
• Beta (1Y): 0.80
• Revenue Growth: -0.93%
• EPS Growth: -37.97%
• Country: JP
• Employees: 4,573
• Sector: Technology
• Sector Strength: 90
• Industry: Information Technology Services
• EPS (TTM): 247.06
• Shares Outstanding: 16,044,000
• 10 Day Avg. Volume: 20,160
• 30 Day Avg. Volume: 30,780
• PEG Ratio: -0.84
• Price to Book (P/B): 1.01
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥5,034.00
• Price Target Upside: 6.99% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 67 Neutral
• Price Target: ¥4,948.00 ▲(5.16%Upside)

Mitsubishi Research Institute's overall stock score of 67 reflects strong balance sheet health and reasonable valuation. However, revenue growth challenges and cash flow volatility pose risks. Technical indicators present a neutral to slightly bearish outlook, emphasizing the need for strategic improvements.

Mitsubishi Research Institute Business Overview & Revenue Model

Company Description

Mitsubishi Research Institute (MRI) is a leading Japanese think tank and consulting firm headquartered in Tokyo. It operates across multiple sectors including information technology, environment, energy, health care, and finance. MRI offers a wide range of services such as research and analysis, consulting, and system development to help clients address complex challenges and make informed decisions.

How the Company Makes Money

Mitsubishi Research Institute generates revenue primarily through its consulting and research services. The company earns fees by providing strategic advice, detailed research reports, and technological solutions to both public and private sector clients. MRI also engages in system development and implementation projects, which contribute significantly to its income. Additionally, the company benefits from long-term partnerships and collaborations with government bodies, corporations, and international organizations, ensuring a steady stream of projects and contracts.

Mitsubishi Research Institute Financial Statement Overview

Summary

Mitsubishi Research Institute presents a solid financial footing with strong balance sheet metrics and operational efficiency. The income statement reflects moderate performance due to inconsistent revenue growth. Cash flow volatility poses risks, highlighting the need for improved cash management.

Income Statement

The income statement reflects moderate performance. The TTM gross profit margin is approximately 22.45%, while the net profit margin is 4.17%. Both margins indicate effective cost control but could benefit from improvement. Revenue growth has been inconsistent, with a decline in recent periods, suggesting challenges in maintaining top-line growth. EBIT and EBITDA margins are healthy at 5.64% and 9.38% respectively, indicating operational efficiency.

Balance Sheet

The balance sheet is strong, with low leverage and a healthy equity base. The debt-to-equity ratio is conservative at approximately 0.01, reflecting minimal financial risk. The return on equity is satisfactory at 7.15%, indicating efficient use of equity capital. With an equity ratio of 57.15%, the company maintains a robust capital structure, ensuring financial stability.

Cash Flow

Cash flow analysis shows mixed results. While free cash flow has shown volatility, the operating cash flow to net income ratio was not calculable due to missing data for the latest TTM period. Historical cash flow performance suggests room for improvement in cash flow management, especially in converting net income to cash.

Breakdown	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020
Income Statement
Total Revenue	115.36B	122.13B	116.62B	103.03B	92.02B
Gross Profit	25.42B	25.98B	26.58B	23.45B	21.24B
EBITDA	11.75B	13.40B	15.80B	11.48B	14.35B
Net Income	5.00B	6.29B	7.71B	5.01B	7.10B
Balance Sheet
Total Assets	119.73B	118.01B	114.65B	99.70B	96.25B
Cash, Cash Equivalents and Short-Term Investments	30.93B	25.23B	33.16B	29.40B	32.74B
Total Debt	1.11B	2.09B	3.53B	4.93B	4.89B
Total Liabilities	43.36B	43.63B	43.50B	35.87B	34.71B
Stockholders Equity	67.63B	65.80B	63.05B	56.28B	53.86B
Cash Flow
Free Cash Flow	9.41B	219.00M	6.07B	636.00M	5.98B
Operating Cash Flow	13.54B	5.70B	9.26B	3.25B	8.64B
Investing Cash Flow	-2.91B	-2.41B	-6.65B	-1.97B	-749.00M
Financing Cash Flow	-4.94B	-6.20B	-3.85B	-4.62B	-1.11B

Mitsubishi Research Institute Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 4705.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3636, the sentiment is Positive. The current price of 4705 is above the 20-day moving average (MA) of 4578.00, above the 50-day MA of 4570.90, and above the 200-day MA of 4533.89, indicating a bullish trend. The MACD of 17.37 indicates Negative momentum. The RSI at 63.82 is Neutral, neither overbought nor oversold. The STOCH value of 76.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3636.

Mitsubishi Research Institute Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2317	82 Outperform	¥144.59B	17.22		2.99%	8.68%	24.54%
9715	78 Outperform	¥130.59B	11.44	9.87%	3.04%	3.77%	12.41%
4722	73 Outperform	¥198.83B	19.85		1.99%	19.53%	9.84%
9682	73 Outperform	$177.73B	19.19	17.46%	2.52%	8.80%	50.65%
9889	73 Outperform	¥89.08B	17.27		5.09%	7.17%	45.75%
Sector *	68 Neutral	¥234.20B	14.88	7.50%	2.60%	9.27%	5.76%
3636	67 Neutral	¥74.49B	20.17		3.40%	-0.93%	-37.97%

Mitsubishi Research Institute Corporate Events

Mitsubishi Research Institute Reports Decline in Semi-Annual Financial Results

Mitsubishi Research Institute reported a decrease in its consolidated financial results for the six months ended March 31, 2025, with net sales dropping by 1.6% and operating profit declining by 20.7% compared to the previous year. Despite these challenges, the company maintains a strong equity-to-asset ratio and has revised its earnings forecasts, indicating strategic adjustments to navigate the current market conditions.